These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8807673

  • 1. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A, Mistry K, Diecke FP, Cruz E.
    Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.
    Ramasamy R, Liu H, Oates PJ, Schaefer S.
    Cardiovasc Res; 1999 Apr; 42(1):130-9. PubMed ID: 10435004
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A, Diecke FP, Mistry K, Cruz E.
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [Abstract] [Full Text] [Related]

  • 4. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA, Rafford CE, Goddu KJ, Ashton MA, Beyer TA, Hutson NJ.
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [Abstract] [Full Text] [Related]

  • 5. Dietary myo-inositol effect on sugar cataractogenesis.
    Beyer-Mears A, Bucci FA, Del Val M, Cruz E.
    Pharmacology; 1989 Dec; 39(1):59-68. PubMed ID: 2587618
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG, Fathallah L.
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [Abstract] [Full Text] [Related]

  • 7. Reduced Na(+)-K+ pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibition.
    Tesfamariam B, Gupta S, Oates PJ, Ruderman NB, Cohen RA.
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1189-94. PubMed ID: 8238405
    [Abstract] [Full Text] [Related]

  • 8. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 9. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 10. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
    Gervasi GB, Bartoli C, Catalani R, Farina C, Carpita G, Caccia G, Ammannati P.
    Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
    [Abstract] [Full Text] [Related]

  • 11. Comparison of sorbinil and ponalrestat (Statil) diminution of proteinuria in the BB rat.
    Beyer-Mears A, Murray FT, Cruz E, Rountree J, Sciadini M.
    Pharmacology; 1992 Nov; 45(5):285-91. PubMed ID: 1465475
    [Abstract] [Full Text] [Related]

  • 12. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
    Kawakubo K, Mori A, Sakamoto K, Nakahara T, Ishii K.
    Biol Pharm Bull; 2012 Nov; 35(6):866-72. PubMed ID: 22687477
    [Abstract] [Full Text] [Related]

  • 13. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R, Oates PJ, Schaefer S.
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [Abstract] [Full Text] [Related]

  • 14. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A, Diecke FP, Mistry K, Ellison C, Cruz E.
    Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats.
    Inskeep PB, Reed AE, Ronfeld RA.
    Pharm Res; 1991 Dec; 8(12):1511-5. PubMed ID: 1808615
    [Abstract] [Full Text] [Related]

  • 16. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J, Kim CS, Sohn E, Lee YM, Kim JS.
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [Abstract] [Full Text] [Related]

  • 17. Featured Article: Inhibition of diabetic cataract by glucose tolerance factor extracted from yeast.
    Mirsky N, Cohen R, Eliaz A, Dovrat A.
    Exp Biol Med (Maywood); 2016 Apr; 241(8):817-29. PubMed ID: 26825353
    [Abstract] [Full Text] [Related]

  • 18. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.
    Trueblood N, Ramasamy R.
    Am J Physiol; 1998 Jul; 275(1):H75-83. PubMed ID: 9688898
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V, Kumar PA, Naik RR, Sridhar G, Kumar MP, Gopal VV, Raju TN.
    J Ethnopharmacol; 2013 Aug 26; 149(1):215-21. PubMed ID: 23827758
    [Abstract] [Full Text] [Related]

  • 20. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S, Kikuchi C, Ono T, Notsu Y.
    Invest Ophthalmol Vis Sci; 1991 Nov 26; 32(12):3078-83. PubMed ID: 1834606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.